Impact of age on elderly patients with oral cancer
- 66 Downloads
In this study we have tried to analyze the impact of age on various clinico-pathological parameters, treatment completion and subsequent survival in older patients.
Materials and methods
This is a retrospective analysis of 140 elderly (> 65 years) patients of oral cancer operated between January 2012 and December 2013. The patients were divided into two groups based upon their age that ≤ 70 years and > 70 years.Association of distribution of various clinico-pathological factors between different groups was assessed by using Chi-square test. Survival analysis was done using Kaplan Meir analysis. Univariate and multivariate analysis were performed.
The two groups had similar distribution of various clinico-pathological factors. Disease free survival for the group ≤ 70 and > 70 years was 37.6 months and 36.4 months (p < 0.594). 13.5% and 7.8% patients > 70 years and ≤ 70 years were either advised or received sub-optimal adjuvant therapy (p < 0.002).
There is no difference distribution of various clinico-pathological factors and survival in patients of oral cancer ≤ 70 and > 70 years of age. Age did not affect survival. Majority of patients could complete the adjuvant therapy advised. Still, significantly more number of patients > 70 years could not receive/complete appropriate adjuvant therapy. Thus treatment needs to be tailored keeping in mind the individual’s performance status and the co-morbidities.
KeywordsOral cancer Geriatric patients Survival Age Adjuvant therapy
Compliance with ethical standards
Conflict of interest
The authors declare that there is no conflict of interest.
- 2.Swaminathan D, Swaminathan V (2015 Dec) Geriatric oncology: problems with under-treatment within this population. Cancer Biol Med 12(4):275–283Google Scholar
- 7.Gugić J, Strojan P (2012 Aug) Squamous cell carcinoma of the head and neck in the elderly. Rep Pract Oncol Radiother 10(1):16–25 18(Google Scholar
- 23.Porceddu SV, Haddad RI. Management of elderly patients with locoregionally confined head and neck cancer. Lancet Oncol 2017 May 1;18(5):e274–83Google Scholar